Developing compliance instructions for drug labeling

Clinical Pharmacology and Therapeutics

Volumn 68, Issue 6, 2000, Pages 586-591

  Levy, Gerhard ^a   Zamacona, Miren K ^b   Jusko, William J ^b  

^a UNIVERSITY AT BUFFALO   (United States)

^b STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG;

DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG HALF LIFE; DRUG INFORMATION; DRUG LABELING; DRUG METABOLISM; DRUG MONITORING; HOSPITAL ADMISSION; MEDICAL ETHICS; NOTE; PATIENT COMPLIANCE; PRIORITY JOURNAL; SIMULATION; STEADY STATE;

COMPUTER SIMULATION; DRUG ADMINISTRATION SCHEDULE; DRUG LABELING; HUMANS; MODELS, BIOLOGICAL; PATIENT EDUCATION; PHARMACOKINETICS; TREATMENT REFUSAL;

EID: 0034527147     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1067/mcp.2000.110976     Document Type: Note

References (9)

1. Assessment and reporting of clinical pharmacology information in drug labeling
2. Erratic patient compliance with prescribed drug regimens: Target for drug delivery systems
3. Failure to comply: A therapeutic dilemma and the bane of clinical trials
4. Variable patient compliance as a source of variability in drug response
5. Kinetics of pharmacologic effects
6. A pharmacokinetic perspective on medicament noncompliance
7. Physiologic indirect response models characterize diverse types of pharmacodynamic effects
8. ADAPT II Program Menu: Pharmacokinetic/pharmacodynamic systems analysis
9. Mechanism-based pharmacodynamic modeling